More accountable care organizations are taking on downside financial risk in the Medicare Shared Savings Program than ever before, with 37% in the program today participating in these arrangements.

The Supreme Court won’t take up the ongoing appeal over the constitutionality of the Affordable Care Act, leaving the decision in the hands of a lower court.

The world could soon have a new most expensive drug if an experimental gene therapy for hemophilia patients could come in with a price tag between $2 million and $3 million is approved.

Sundar Pichai, who serves as the CEO for both Alphabet and Google, wants the United States and European Union to work together on developing AI regulations.

The Centers for Medicare & Medicaid Innovation savings projections keep moving, underscoring just how difficult it is to estimate the impact of untested alternative payment models, according to a recent analysis from Avalere Health.

The American College of Physicians, which represents 159,000 internists in the U.S., has endorsed a single-payer American healthcare system.

HHS Secretary Alex Azar took some heat from President Trump after a recent poll showed Democrats leading when it came to the issue of healthcare.

AI is poised to change the healthcare industry forever—but risks remain that researchers must take seriously.